Concepts (68)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA-Binding Proteins | 4 | 2011 | 1893 | 0.150 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2020 | 792 | 0.130 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2010 | 2937 | 0.090 |
Why?
|
| Sexual Maturation | 1 | 2010 | 265 | 0.080 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2009 | 427 | 0.080 |
Why?
|
| Body Size | 1 | 2010 | 457 | 0.070 |
Why?
|
| Adenine | 1 | 2009 | 940 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2020 | 4671 | 0.060 |
Why?
|
| Benzamides | 1 | 2009 | 1373 | 0.060 |
Why?
|
| Glucose | 2 | 2011 | 4376 | 0.050 |
Why?
|
| Hematopoiesis | 1 | 2010 | 2055 | 0.050 |
Why?
|
| MicroRNAs | 3 | 2011 | 3710 | 0.050 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 2693 | 0.050 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2020 | 53 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2009 | 2454 | 0.050 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2020 | 114 | 0.040 |
Why?
|
| Stroke | 1 | 2020 | 9898 | 0.040 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2020 | 474 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2009 | 5148 | 0.030 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2010 | 3487 | 0.030 |
Why?
|
| Mice, Transgenic | 3 | 2011 | 9738 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2009 | 5500 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 8395 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2009 | 9625 | 0.030 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2010 | 649 | 0.020 |
Why?
|
| Mice | 5 | 2011 | 80995 | 0.020 |
Why?
|
| Radiology | 1 | 2020 | 2080 | 0.020 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2009 | 683 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 14721 | 0.020 |
Why?
|
| Time Factors | 2 | 2020 | 40040 | 0.010 |
Why?
|
| Models, Animal | 1 | 2010 | 2166 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4746 | 0.010 |
Why?
|
| Thiazoles | 1 | 2009 | 1486 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 3599 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3922 | 0.010 |
Why?
|
| Animals | 5 | 2011 | 168358 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 6391 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2010 | 4205 | 0.010 |
Why?
|
| Binding Sites | 1 | 2009 | 6116 | 0.010 |
Why?
|
| Neoplasms | 1 | 2009 | 21499 | 0.010 |
Why?
|
| Piperazines | 1 | 2009 | 2480 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2010 | 3369 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2011 | 3858 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2009 | 2917 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2009 | 2185 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 20038 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2011 | 14555 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2009 | 6218 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2010 | 6236 | 0.010 |
Why?
|
| Insulin | 1 | 2010 | 6568 | 0.010 |
Why?
|
| Cell Line | 1 | 2009 | 15982 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 19223 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 9393 | 0.010 |
Why?
|
| Humans | 6 | 2020 | 739219 | 0.010 |
Why?
|
| Models, Biological | 1 | 2010 | 9598 | 0.010 |
Why?
|
| Disease Progression | 1 | 2010 | 13237 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2009 | 4214 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 12064 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 16624 | 0.010 |
Why?
|
| Phenotype | 1 | 2010 | 16300 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 12177 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 21859 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 28901 | 0.010 |
Why?
|
| Obesity | 1 | 2011 | 12641 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 11699 | 0.000 |
Why?
|
| Mutation | 1 | 2009 | 29659 | 0.000 |
Why?
|
| Male | 1 | 2010 | 348967 | 0.000 |
Why?
|
| Female | 1 | 2010 | 378808 | 0.000 |
Why?
|
Concepts
(68)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(13)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_